Glazer Capital »

Maywood Acquisition C2-cl-a shares owned by Glazer Capital

Quarter-by-quarter ownership of Maywood Acquisition C2-cl-a shares owned by Glazer Capital from 13F filings

Historical chart of Glazer Capital investment in Maywood Acquisition C2-cl-a

Tip: Access up to 7 years of quarterly data

All positions including Maywood Acquisition C2-cl-a held by Glazer Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maywood Acquisition C2-cl-a by Glazer Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.0k 50k 0.06

More positions owned by Glazer Capital

Topbuild Put Option
Penumbra Put Option (PEN)
Janus Henderson Group Ord Shs
Nuvalent Inc-a (NUVL)
Apogee Therapeutics (APGE)
Select Medical Holdings Corporation
Catalyst Pharmaceutical Partners (CPRX)
HudBay Minerals (HBM)
Digitalbridge Group Cl A New (DBRG)
Chart Industries (GTLS)
Caesars Entertainment (CZR)
Esperion Therapeutics (ESPR)
Webster Financial Corporation (WBS)
Sila Realty Trust Common Stock
Cyberark Software Note 0% 06/15/2030 (Principal)

View all positions for Glazer Capital

Top funds holding Maywood Acquisition C2-cl-a

Polar Securities
CNH Partners
Whitebox Advisors
Wolverine Asset Management
Boothbay Fund Management
Rivernorth Capital Management
D. E. Shaw & Co
Aristeia Capital
Toronto-Dominion Bank
Shaolin Capital Management
Linden Advisors
Radcliffe Capital Management
Bnp Paribas Arbitrage, Snc
Cable Car Capital
Berkley W R

View all funds holding Maywood Acquisition C2-cl-a